Associated Papers
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study.
Bouwmeester RN et al.
Kidney International Reports, 2023
36644349 (PubMed )
Supplement: mmc1.pdf
Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement.
Noris M et al.
Seminars in Nephrology, 2017
Select a paper to view details